192 related articles for article (PubMed ID: 29901196)
1. Telomerase reverse transcriptase induced thyroid carcinoma cell proliferation through PTEN/AKT signaling pathway.
Zhang H; Hu N
Mol Med Rep; 2018 Aug; 18(2):1345-1352. PubMed ID: 29901196
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
[TBL] [Abstract][Full Text] [Related]
3. miR-222 induces Adriamycin resistance in breast cancer through PTEN/Akt/p27
Wang DD; Yang SJ; Chen X; Shen HY; Luo LJ; Zhang XH; Zhong SL; Zhao JH; Tang JH
Tumour Biol; 2016 Nov; 37(11):15315-15324. PubMed ID: 27699665
[TBL] [Abstract][Full Text] [Related]
4. Cytosolic phospholipase A2α sustains pAKT, pERK and AR levels in PTEN-null/mutated prostate cancer cells.
Hua S; Yao M; Vignarajan S; Witting P; Hejazi L; Gong Z; Teng Y; Niknami M; Assinder S; Richardson D; Dong Q
Biochim Biophys Acta; 2013 Jun; 1831(6):1146-57. PubMed ID: 23500889
[TBL] [Abstract][Full Text] [Related]
5. PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer.
Guigon CJ; Zhao L; Willingham MC; Cheng SY
Oncogene; 2009 Jan; 28(4):509-17. PubMed ID: 18997818
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of
Yao LZ; Zhu YL; Liu JJ
Technol Cancer Res Treat; 2020; 19():1533033820917959. PubMed ID: 32281513
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA‑4712‑5p promotes proliferation of the vulvar squamous cell carcinoma cell line A431 by targeting PTEN through the AKT/cyclin D1 signaling pathways.
Yang S; Zhao Y; Wang L; Liu C; Lu Y; Fang Z; Shi H; Zhang W; Wu X
Oncol Rep; 2019 Nov; 42(5):1689-1698. PubMed ID: 31545465
[TBL] [Abstract][Full Text] [Related]
9. PIG3 plays an oncogenic role in papillary thyroid cancer by activating the PI3K/AKT/PTEN pathway.
Xu J; Cai J; Jin X; Yang J; Shen Q; Ding X; Liang Y
Oncol Rep; 2015 Sep; 34(3):1424-30. PubMed ID: 26133772
[TBL] [Abstract][Full Text] [Related]
10. miR-21 inhibitor suppresses cell proliferation and colony formation through regulating the PTEN/AKT pathway and improves paclitaxel sensitivity in cervical cancer cells.
Du G; Cao D; Meng L
Mol Med Rep; 2017 May; 15(5):2713-2719. PubMed ID: 28447761
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA‑142‑5p modulates breast cancer cell proliferation and apoptosis by targeting phosphatase and tensin homolog.
Xu W; Wang W
Mol Med Rep; 2018 Jun; 17(6):7529-7536. PubMed ID: 29620260
[TBL] [Abstract][Full Text] [Related]
12. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus X protein increases microRNA‑21 expression and accelerates the development of hepatoma via the phosphatase and tensin homolog/phosphoinositide 3‑kinase/protein kinase B signaling pathway.
Hou Z; Quan J
Mol Med Rep; 2017 May; 15(5):3285-3291. PubMed ID: 28339072
[TBL] [Abstract][Full Text] [Related]
14. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway.
Xu J; Li Z; Su Q; Zhao J; Ma J
Oncol Rep; 2017 Mar; 37(3):1555-1564. PubMed ID: 28098872
[TBL] [Abstract][Full Text] [Related]
15. [Effects of PTEN over-expression on phosphatidyl inositol 3-kinase/protein kinase B signal pathway in ovarian epithelial cancer cells].
Zhai YN; Xu LL; Shen Y; Xia H; Shen YF
Zhonghua Fu Chan Ke Za Zhi; 2010 Sep; 45(9):682-5. PubMed ID: 21092549
[TBL] [Abstract][Full Text] [Related]
16. Telomerase reverse transcriptase regulates DNMT3B expression/aberrant DNA methylation phenotype and AKT activation in hepatocellular carcinoma.
Yu J; Yuan X; Sjöholm L; Liu T; Kong F; Ekström TJ; Björkholm M; Xu D
Cancer Lett; 2018 Oct; 434():33-41. PubMed ID: 30017965
[TBL] [Abstract][Full Text] [Related]
17. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
Wang H; Chen B; Duan B; Zheng J; Wu X
Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
[TBL] [Abstract][Full Text] [Related]
18. Honokiol suppresses proliferation and induces apoptosis via regulation of the miR‑21/PTEN/PI3K/AKT signaling pathway in human osteosarcoma cells.
Yang J; Zou Y; Jiang D
Int J Mol Med; 2018 Apr; 41(4):1845-1854. PubMed ID: 29393336
[TBL] [Abstract][Full Text] [Related]
19. PI3K/AKT Pathway and Its Mediators in Thyroid Carcinomas.
Nozhat Z; Hedayati M
Mol Diagn Ther; 2016 Feb; 20(1):13-26. PubMed ID: 26597586
[TBL] [Abstract][Full Text] [Related]
20. [Rosiglitazone inhibits human HepG2 cell proliferation via PI3K/PTEN/Akt signaling pathway].
Zhang M; Peng L; Qiao Z; He H; Zhou Y; Xu Z
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 Feb; 30(2):147-50. PubMed ID: 24491054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
